Success Metrics

Clinical Success Rate
81.8%

Based on 9 completed trials

Completion Rate
82%(9/11)
Active Trials
3(14%)
Results Posted
67%(6 trials)
Terminated
2(10%)

Phase Distribution

Ph not_applicable
14
67%
Ph phase_2
4
19%
Ph phase_4
2
10%
Ph phase_3
1
5%

Phase Distribution

0

Early Stage

4

Mid Stage

3

Late Stage

Phase Distribution21 total trials
Phase 2Efficacy & side effects
4(19.0%)
Phase 3Large-scale testing
1(4.8%)
Phase 4Post-market surveillance
2(9.5%)
N/ANon-phased studies
14(66.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

64.3%

9 of 14 finished

Non-Completion Rate

35.7%

5 ended early

Currently Active

3

trials recruiting

Total Trials

21

all time

Status Distribution
Active(3)
Completed(9)
Terminated(5)
Other(4)

Detailed Status

Completed9
Recruiting3
unknown3
Withdrawn3
Terminated2
Suspended1

Development Timeline

Analytics

Development Status

Total Trials
21
Active
3
Success Rate
81.8%
Most Advanced
Phase 4

Trials by Phase

Phase 24 (19.0%)
Phase 31 (4.8%)
Phase 42 (9.5%)
N/A14 (66.7%)

Trials by Status

completed943%
recruiting314%
suspended15%
unknown314%
terminated210%
withdrawn314%

Recent Activity

Clinical Trials (21)

Showing 20 of 21 trialsScroll for more
NCT02326337Not Applicable

Efficacy, Safety and Economic Benefits of Topical Wound Oxygen Therapy in the Treatment of Chronic Diabetic Foot Ulcers

Completed
NCT06817161Phase 3

Benefit of Transcutaneous Auricular Vagus Nerve Stimulation in Improving Quality of Life in First Line Treatment of Ovarian Cancer:

Recruiting
NCT06676488Not Applicable

A Randomized Crossover Trial of Bright Light Therapy in Irritable Bowel Syndrome

Recruiting
NCT03360214Phase 4

PEMF and PEC Blocks in Mastectomy Reconstruction Patients

Completed
NCT06132776Not Applicable

The Mamma HiToP Study

Recruiting
NCT04149951Not Applicable

Effect of VeSTAL Device in Type 2 Diabetes Mellitus

Completed
NCT04797884Phase 2

Electromagnetic Fields Versus Placebo For Child-Pugh A and B Patients With Advanced Hepatocellular Carcinoma

Unknown
NCT05157399Not Applicable

Quantification of the Effect of the OtoBand on Objective Measures of Vertigo and Dizziness

Completed
NCT04219566Not Applicable

Vestibular Nerve Stimulation to Improve Sleep

Completed
NCT04226976Not Applicable

Efficacy of a Non-invasive Vestibular System Masking for Improving Outcomes Following Acute Unilateral Vestibulopathy

Suspended
NCT03996863Not Applicable

Prevention of Unmitigated Chemotherapy-induced Emesis

Withdrawn
NCT04526080Phase 2

Intrabucally Administered Electromagnetic Fields Versus Placebo as Third-line Therapy For Patients With Advanced Hepatocellular Carcinoma

Withdrawn
NCT01771575Not Applicable

The Use of the PoNS™ Device in the Treatment of Blunt and Blast Induced Vestibular Disorders

Withdrawn
NCT03397472Not Applicable

Magnetic Field Modulation Pillow for Insomnia Clinical Trial

Completed
NCT00586170Not Applicable

A Double-Blind Study on Adjunctive Use of PEMF in the Treatment of 5th Metatarsal Non-Union Fractures

Terminated
NCT02829073Not Applicable

Treating Tinnitus Using the Neuromonics Tinnitus Treatment Program: A Randomized, Double-blind Study

Unknown
NCT01702259Not Applicable

Study of the Effect of Low Level Laser Light Therapy on Reducing the Appearance of Cellulite in the Thighs and Buttocks.

Completed
NCT01016691Phase 2

Safety and Efficacy of a Drug Delivery System in Glaucoma

Completed
NCT00824720Phase 2

Safety and Efficacy of a Glaucoma Drug Delivery System

Completed
NCT00646971Not Applicable

Oxidative Stress and Endothelial Dysfunction in Obstructive Sleep Apnea

Terminated

Drug Details

Intervention Type
DEVICE
Total Trials
21